Cargando…
How COVID-19 induces cytokine storm with high mortality
The newly emerging coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, but has rapidly spread all over the world. Some COVID-19 patients encounter a severe symptom of acute respiratory distress syndrome (ARDS)...
Autores principales: | Hojyo, Shintaro, Uchida, Mona, Tanaka, Kumiko, Hasebe, Rie, Tanaka, Yuki, Murakami, Masaaki, Hirano, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527296/ https://www.ncbi.nlm.nih.gov/pubmed/33014208 http://dx.doi.org/10.1186/s41232-020-00146-3 |
Ejemplares similares
-
Gateway Reflex and Mechanotransduction
por: Matsuyama, Shiina, et al.
Publicado: (2021) -
In situ Microinflammation Detection Using Gold Nanoclusters and a Tissue-clearing Method
por: Naim, Fayrouz, et al.
Publicado: (2023) -
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
por: Hirano, Toshio, et al.
Publicado: (2020) -
Rhodobacter azotoformans LPS (RAP99-LPS) Is a TLR4 Agonist That Inhibits Lung Metastasis and Enhances TLR3-Mediated Chemokine Expression
por: Murakami, Kaoru, et al.
Publicado: (2021) -
Gateway reflexes describe novel neuro-immune communications that establish immune cell gateways at specific vessels
por: Tanaka, Hiroki, et al.
Publicado: (2023)